1. Home
  2. CTBI vs ABUS Comparison

CTBI vs ABUS Comparison

Compare CTBI & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTBI
  • ABUS
  • Stock Information
  • Founded
  • CTBI 1903
  • ABUS 2005
  • Country
  • CTBI United States
  • ABUS United States
  • Employees
  • CTBI N/A
  • ABUS 44
  • Industry
  • CTBI Major Banks
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTBI Finance
  • ABUS Health Care
  • Exchange
  • CTBI Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • CTBI 959.5M
  • ABUS 828.9M
  • IPO Year
  • CTBI N/A
  • ABUS N/A
  • Fundamental
  • Price
  • CTBI $55.41
  • ABUS $4.40
  • Analyst Decision
  • CTBI Buy
  • ABUS Strong Buy
  • Analyst Count
  • CTBI 3
  • ABUS 2
  • Target Price
  • CTBI $59.00
  • ABUS $5.00
  • AVG Volume (30 Days)
  • CTBI 62.0K
  • ABUS 1.1M
  • Earning Date
  • CTBI 10-15-2025
  • ABUS 11-13-2025
  • Dividend Yield
  • CTBI 3.83%
  • ABUS N/A
  • EPS Growth
  • CTBI 17.49
  • ABUS N/A
  • EPS
  • CTBI 5.17
  • ABUS N/A
  • Revenue
  • CTBI $261,447,000.00
  • ABUS $14,606,000.00
  • Revenue This Year
  • CTBI $21.01
  • ABUS $138.02
  • Revenue Next Year
  • CTBI $6.33
  • ABUS N/A
  • P/E Ratio
  • CTBI $10.71
  • ABUS N/A
  • Revenue Growth
  • CTBI 13.97
  • ABUS 116.64
  • 52 Week Low
  • CTBI $44.60
  • ABUS $2.71
  • 52 Week High
  • CTBI $61.67
  • ABUS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • CTBI 59.03
  • ABUS 46.95
  • Support Level
  • CTBI $52.55
  • ABUS $4.08
  • Resistance Level
  • CTBI $54.77
  • ABUS $4.87
  • Average True Range (ATR)
  • CTBI 1.04
  • ABUS 0.23
  • MACD
  • CTBI 0.31
  • ABUS -0.04
  • Stochastic Oscillator
  • CTBI 79.88
  • ABUS 36.71

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: